Biopsy is defined as a procedure that is performed for removing cells or tissue from the patient’s body for further examination under a microscope. Lung Biopsy includes the extraction of samples of lung tissues for the determination of any lung disease like lung cancer. Lung biopsy systems are designed for either an open lung biopsy or closed lung biopsy. Closed methods are usually performed through the windpipe (trachea) or through the skin, wherein, an open biopsy is performed under general anesthesia in an operating room. Lung biopsy systems are required for performing lung biopsy for determination of various lung-related issues, and is recommended after abnormalities in the chest are found post chest x-ray or a computerized tomography scan. Post determination, lung biopsy systems are also helpful in determining what stage of lung cancer it is in a patient. Diagnosing lung cancer in its initial stages might help in decreasing the mortality rates. As per the American Cancer Society, the number of incidence cases for lung cancer were approximately around 228,150 for 2019 in the United States. This increasing incidence demands the urgency of more efficient, less invasive, and accurate diagnostic systems like lung biopsy systems across regions. Lung biopsy systems are recognized as one of the most essential tools for diagnosis as well as for the treatment of lung cancer.
Lung Biopsy Systems Market: Drivers and Restraints-
Incidence of lung cancer has been rising in the higher income countries owing it to the growing unhealthy lifestyle trend. This rise in lung cancer cases is expected to propel demand for lung biopsy systems for detection and treatment of lung cancer, which is expected to further fuel market growth for lung biopsy systems during the forecast period. Several combination lung biopsy systems and technological advancements for lung biopsy systems is also expected to contribute to boost the market growth for lung biopsy systems during the forecast period. Increase in healthcare expenditure around the globe and growth of medical devices industry across region could also favor the lung biopsy systems market growth over the forecast period. However, high costs associated with lung biopsy systems and lack of awareness of lung biopsy systems in low economy regions might hamper market growth for lung biopsy systems over the forecast period.
Download sample copy of this report:
Lung Biopsy Systems Market: Segmentation
On the basis of product type, Lung Biopsy Systems Market can be segmented as:
- Core Needle Biopsy Devices
- Fine Needle Aspiration Biopsy Devices
- Surgical Biopsy Devices
- Vacuum-Assisted Biopsy Devices
On the basis of procedure type, Lung Biopsy Systems Market can be segmented as:
- Needle biopsy
- Thoracoscopic biopsy
- Transbronchial biopsy
- Open biopsy
On the basis of end use, Lung Biopsy Systems Market can be segmented as:
- Cancer Research Centers
- Specialty Clinics
Download Table of Contents@ https://www.futuremarketinsights.com/toc/rep-gb-9349
Lung Biopsy Systems Market: Overview
Spiraling demand for disposable lung biopsy systems and less invasive surgeries is anticipated to fuel market demand for lung biopsy systems. There have been constant technological advancements for lung biopsy systems over the years, with regards to guidance systems like vacuum assisted guns. These technological advancements have gained a lot of popularity by the end use, majorly hospitals. Widening base of elderly population and introduction of cost-effective and advanced lung biopsy systems are anticipated to boost demand for lung biopsy systems across regions. Needle based lung biopsy systems are expected to contribute a huge revenue share to the lung biopsy systems market owing it to the constant advancements and launch of these systems.
Lung Biopsy Systems Market: Region-wise Outlook
North America and Europe’s lung biopsy systems market is expected to propel major growth of the global lung biopsy systems market, owing it to the innovations and product approvals of these systems for lung cancer screening. High prevalence rates of lung cancer and increasing number of lung biopsy systems manufacturers in these regions is also expected to boost demand for lung biopsy systems in the region. Asia-pacific market for lung biopsy systems, majorly, Japan, China, and Korea are expected to increase significantly during the forecast period, because of the growing awareness on lung cancer, rise in geriatric population and high incidence rates due to increased lifespan in these regions.
Download table of contents with figures & tables:
Lung Biopsy Systems Market: Key Market Participants
Some of the market participants in the Global Lung Biopsy Systems market identified across the value chain include: BD, Medtronic, DTR Medical, B. Braun Melsungen AG, Argon Medical Devices, Cardinal Health, Hologic, Inc., Fujifilm Medical Systems, and Olympus Corporation.